Engeneic

Engeneic company information, Employees & Contact Information

Explore related pages

Engeneic email format Engeneic management contacts

Related company profiles:

EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.

Company Details

Employees
45
Founded
-
Address
11 Julius Avenue, Level 4,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
http://engeneic.com/
Keywords
Biotechnology, Cancer therapeutics, Bioprocessing, Nanotechnology.
HQ
North Ryde, New South Wales
Competitors
Aegros, Vow, SpeeDx Pty Ltd, Inventia Life Science, VentureCrowd, TissueLabs, AusDiagnostics, Genetic Signatures, Resmed, AusBiotech.
Looking for a particular Engeneic employee's phone or email?

Engeneic Questions

News

EnGeneIC launches groundbreaking new Australian trial for - GlobeNewswire

EnGeneIC launches groundbreaking new Australian trial for GlobeNewswire

EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia - Yahoo Finance

EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia Yahoo Finance

EnGeneIC Wins Innovation Award from Australian Financial Review - PR Newswire

EnGeneIC Wins Innovation Award from Australian Financial Review PR Newswire

Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern - Frontiers

Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern Frontiers

Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells - ScienceDirect.com

Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells ScienceDirect.com

Why investors have put $100m behind Australian biotech’s ‘Trojan horse’ for cancer - Forbes Australia

Why investors have put $100m behind Australian biotech’s ‘Trojan horse’ for cancer Forbes Australia

EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options - Yahoo Finance

EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options Yahoo Finance

EnGeneIC Pty Ltd's Joint-CEO And Co-Founder, Jennifer Macdiarmid, Ph.D., Recognized In Innovation Category In The Australian Financial Review And Westpac 100 Women Of Influence Awards For 2016 - BioSpace

EnGeneIC Pty Ltd's Joint-CEO And Co-Founder, Jennifer Macdiarmid, Ph.D., Recognized In Innovation Category In The Australian Financial Review And Westpac 100 Women Of Influence Awards For 2016 BioSpace

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy - BiotechDispatch

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy BiotechDispatch

Distinguished Oncologist, Professor Daniel Von Hoff joins - GlobeNewswire

Distinguished Oncologist, Professor Daniel Von Hoff joins GlobeNewswire

FDA grants fast-track designation for EnGeneIC's pancreatic cancer candidate - BiotechDispatch

FDA grants fast-track designation for EnGeneIC's pancreatic cancer candidate BiotechDispatch

Small Sydney company strikes billion-dollar biotech deal for groundbreaking treatments - 9News

Small Sydney company strikes billion-dollar biotech deal for groundbreaking treatments 9News

EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells - PR Newswire

EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells PR Newswire

Australian Biotech EnGeneIC Strikes Landmark Deal with - GlobeNewswire

Australian Biotech EnGeneIC Strikes Landmark Deal with GlobeNewswire

Australian biotech, EnGeneIC, develops world-first - GlobeNewswire

Australian biotech, EnGeneIC, develops world-first GlobeNewswire

EnGeneIC’s second generation COVID-19 vaccine protects against all variants - GlobeNewswire

EnGeneIC’s second generation COVID-19 vaccine protects against all variants GlobeNewswire

Companies like Engeneic

TissueLabs logo - Similar company to Engeneic

Tissuelabs

14
Aegros logo - Similar company to Engeneic

Aegros

65
Resmed logo - Similar company to Engeneic

Resmed

8.40K
VentureCrowd logo - Similar company to Engeneic

Venturecrowd

44
AusBiotech logo - Similar company to Engeneic

Ausbiotech

83
AusDiagnostics logo - Similar company to Engeneic

Ausdiagnostics

83
Genetic Signatures logo - Similar company to Engeneic

Genetic Signatures

98
Vow logo - Similar company to Engeneic

Vow

111
Inventia Life Science logo - Similar company to Engeneic

Inventia Life Science

67
SpeeDx Pty Ltd logo - Similar company to Engeneic

Speedx Pty Ltd

83

Top Engeneic Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant